{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:56:13Z","timestamp":1784030173492,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Laboratory Project of Neurological Diseases in Jiangxi Province","award":["2024SSY06072"],"award-info":[{"award-number":["2024SSY06072"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62560279"],"award-info":[{"award-number":["62560279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04615-5","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:53:48Z","timestamp":1769244828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-mGluR encephalitis: case series and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Yajie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"1","key":"4615_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-020-00024-x","volume":"2","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Honnorat J, Yamaguchi K, Manto M. Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies. Mol Biomed. 2021;2(1):2.","journal-title":"Mol Biomed"},{"issue":"1","key":"4615_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25\u201336.","journal-title":"Ann Neurol"},{"key":"4615_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839\u201387.","journal-title":"Physiol Rev"},{"key":"4615_CR4","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/mds.25561","volume":"28","author":"F Stocchi","year":"2013","unstructured":"Stocchi F, Rascol O, Destee A, et al. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Mov Disord. 2013;28:1838\u201346.","journal-title":"Mov Disord"},{"key":"4615_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00215","volume":"9","author":"A Kumar","year":"2015","unstructured":"Kumar A, Dhull DK, Mishra PS. Therapeutic potential of mGluR5 targeting in Alzheimer\u2019s disease. Front Neurosci. 2015;9:215.","journal-title":"Front Neurosci"},{"key":"4615_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.tins.2014.07.010","volume":"37","author":"BK Atwood","year":"2014","unstructured":"Atwood BK, Lovinger DM, Mathur BN. Presynaptic long-term depression mediated by Gi\/o-coupled receptors. Trends Neurosci. 2014;37:663\u201373.","journal-title":"Trends Neurosci"},{"key":"4615_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","volume":"34","author":"JP Pin","year":"1995","unstructured":"Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and func-tions. Neuropharmacology. 1995;34:1\u201326.","journal-title":"Neuropharmacology"},{"key":"4615_CR8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine JC, et al. Antibodies to metabotropic glutamate receptor 5 in the ophelia syndrome. Neurology. 2011;77:1698\u2013701.","journal-title":"Neurology"},{"key":"4615_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","volume":"91","author":"N Scheefhals","year":"2018","unstructured":"Scheefhals N, MacGillavry HD. Functional organization of postsynaptic glutamate receptors. Mol Cell Neurosci. 2018;91:82\u201394.","journal-title":"Mol Cell Neurosci"},{"issue":"6104","key":"4615_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/325531a0","volume":"325","author":"H Sugiyama","year":"1987","unstructured":"Sugiyama H, Ito I, Hirono C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature. 1987;325(6104):531\u20133.","journal-title":"Nature"},{"issue":"3","key":"4615_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.10451","volume":"53","author":"M Coesmans","year":"2003","unstructured":"Coesmans M, Sillevis Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol. 2003;53(3):325\u201336.","journal-title":"Ann Neurol"},{"key":"4615_CR12","doi-asserted-by":"publisher","first-page":"E3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Petit Pedrol M, Maudes E, Simabukuro M, Mu\u00f1iz-Castrillo S, Pinto AL, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. 2020;95:E3012\u201325.","journal-title":"Neurology"},{"issue":"05","key":"4615_CR13","first-page":"358","volume":"31","author":"MC Gui","year":"2024","unstructured":"Gui MC, Lin J, Ge HZ, et al. Anti-metabotropic glutamate receptor 1 antibody-associated encephalitis: a case report and literature review in Chinese. Chin J Neuroimmunol Neurol. 2024;31(05):358\u201363.","journal-title":"Chin J Neuroimmunol Neurol"},{"issue":"01","key":"4615_CR14","first-page":"86","volume":"32","author":"YQ Liang","year":"2025","unstructured":"Liang YQ, Cao J, Hou YW, et al. Anti-mGluR2 encephalitis presenting primarily with psychiatric symptoms: a case report and literature review in Chinese. Chin J Neuroimmunol Neurol. 2025;32(01):86\u20138.","journal-title":"Chin J Neuroimmunol Neurol"},{"issue":"4","key":"4615_CR15","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/NXI.0000000000001171","volume":"9","author":"AM Vinke","year":"2022","unstructured":"Vinke AM, Zong S, Janssen JH, Correia-Hoffmann C, Man\u00e9-Damas M, Damoiseaux JGMC, et al. Autoimmune encephalitis with mGluR1 antibodies presenting with epilepsy, but without cerebellar signs: a case report. Neurol Neuroimmunol Neuroinflamm. 2022;9(4):e1171.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4615_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12883-025-04345-8","volume":"25","author":"K Yamada","year":"2025","unstructured":"Yamada K, Yaguchi H, Nakamura S, Horiuchi K, Fujii S, Nomura T, Kudo A, Takekoshi A, Yoshikura N, Kimura A, Shimohata T, Yabe I. Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report. BMC Neurol. 2025;25(1):319.","journal-title":"BMC Neurol"},{"issue":"11","key":"4615_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","volume":"86","author":"AS Lopez-Chiriboga","year":"2016","unstructured":"Lopez-Chiriboga AS, Komorowski L, K\u00fcmpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A. Metabotropic glutamate receptor type 1 autoimmunity: clinical features and treatment outcomes. Neurology. 2016;86(11):1009\u201313.","journal-title":"Neurology"},{"key":"4615_CR18","doi-asserted-by":"publisher","first-page":"175628641984741","DOI":"10.1177\/1756286419847418","volume":"12","author":"M Christ","year":"2019","unstructured":"Christ M, M\u00fcller T, Bien C, Hagen T, Naumann M, Bayas A. Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature. Ther Adv Neurol Disord. 2019;12:1756286419847418.","journal-title":"Ther Adv Neurol Disord"},{"key":"4615_CR19","doi-asserted-by":"publisher","first-page":"2329048X2210956","DOI":"10.1177\/2329048X221095695","volume":"9","author":"E Chandler","year":"2022","unstructured":"Chandler E, Arvantis N, Morgan B. A novel case of idiopathic MGluR1 encephalitis in a pediatric patient. Child Neurol Open. 2022;9:2329048X221095695.","journal-title":"Child Neurol Open"},{"key":"4615_CR20","doi-asserted-by":"publisher","first-page":"1333658","DOI":"10.3389\/fneur.2024.1333658","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X, Chen Y, Di L, Liu N, Liu T, Cai Y, Di W. Cerebellar encephalitis associated with anti-mGluR1 antibodies: a case report and comprehensive literature review. Front Neurol. 2024;15:1333658.","journal-title":"Front Neurol"},{"issue":"3","key":"4615_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1159\/000526632","volume":"14","author":"K Sakashita","year":"2023","unstructured":"Sakashita K, Nishida K, Takenaka Y, Yokota I, Yamasaki H, Nishimoto K, et al. Favorable outcome with intravenous immunoglobulin therapy in late-onset anti-mGluR1 encephalitis: a case report and literature review. Case Rep Neurol. 2023;14(3):494\u2013500.","journal-title":"Case Rep Neurol"},{"issue":"1\u20132","key":"4615_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2013.07.015","volume":"263","author":"R Iorio","year":"2013","unstructured":"Iorio R, Damato V, Mirabella M, Vita MG, Hulsenboom E, Plantone D, Bizzarro A, Del Grande A, Sillevis Smitt PA. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma. J Neuroimmunol. 2013;263(1\u20132):155\u20138.","journal-title":"J Neuroimmunol"},{"key":"4615_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.04.001","volume":"319","author":"N Yoshikura","year":"2018","unstructured":"Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, Hayashi Y, Inuzuka T, Shimohata T. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63\u20137.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4615_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mdc3.12841","volume":"6","author":"H Chaumont","year":"2019","unstructured":"Chaumont H, Petit A, Mameri T, Schollhammer R, Honnorat J, Lannuzel A. Successful management of anti-mGluR1 encephalitis with immunosuppressive treatment: dengue virus as a trigger? Mov Disord Clin Pract. 2019;6(8):727\u20138.","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"4615_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mds.27634","volume":"34","author":"C Gollion","year":"2019","unstructured":"Gollion C, Dupouy J, Roberts M, Simonetta-Moreau M, Brefel Courbon C, Rascol O, Honnorat J, Magne FO. Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies. Mov Disord. 2019;34(3):438\u20139.","journal-title":"Mov Disord"},{"issue":"1","key":"4615_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342(1):21\u20137.","journal-title":"N Engl J Med"},{"key":"4615_CR27","doi-asserted-by":"publisher","first-page":"1609389","DOI":"10.3389\/fimmu.2025.1609389","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Ma F, Geng Q, Luo C, Qu C. Case report: coexistence of anti-LGI1 and anti-mGluR2 antibodies in an autoimmune encephalitis patient. Front Immunol. 2025;16:1609389.","journal-title":"Front Immunol"},{"key":"4615_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/ITT.S514617","volume":"14","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Deng X, Guo D, Zhao J, Li J, He F, et al. A case series of anti-Metabotropic glutamate receptor 2 antibody-related diseases with distinct neurological involvement. Immunotargets Ther. 2025;14:465\u201374.","journal-title":"Immunotargets Ther"},{"issue":"2","key":"4615_CR29","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1212\/NXI.0000000000000658","volume":"7","author":"R Ruiz-Garc\u00eda","year":"2019","unstructured":"Ruiz-Garc\u00eda R, Mart\u00ednez-Hern\u00e1ndez E, Joubert B, Petit-Pedrol M, Pajar\u00f3n-Boix E, Fern\u00e1ndez V, Salais L, Del Pozo M, Armangu\u00e9 T, Sabater L, Dalmau J, Graus F. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2. Neurol Neuroimmunol Neuroinflamm. 2019;7(2):e658.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"4615_CR30","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.21037\/qims-22-1185","volume":"13","author":"D Li","year":"2023","unstructured":"Li D, Luo S, Liu C, Lv S, Peng L, Huang W. Anti-metabotropic-glutamate-receptor 2-related encephalitis with cerebellar ataxia: a case description. Quant Imaging Med Surg. 2023;13(7):4770\u20136.","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"4615_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3003","volume":"13","author":"S Chen","year":"2023","unstructured":"Chen S, Ren H, Lin F, Fan S, Cao Y, Zhao W, et al. Anti-metabotropic glutamate receptor 5 encephalitis: five case reports and literature review. Brain Behav. 2023;13(5):e3003.","journal-title":"Brain Behav"},{"issue":"4","key":"4615_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/pn-2024-004089","volume":"24","author":"DA Pedrosa","year":"2024","unstructured":"Pedrosa DA, Ferreira JHF, Gleizer R, Carra RB, de Carvalho RM, Endmayr V, Hoftberger R, Dutra LA. Encephalitis associated with anti-mGluR5 antibodies. Pract Neurol. 2024;24(4):306\u20139.","journal-title":"Pract Neurol"},{"key":"4615_CR33","doi-asserted-by":"publisher","first-page":"1146536","DOI":"10.3389\/fimmu.2023.1146536","volume":"14","author":"K Guo","year":"2023","unstructured":"Guo K, Liu X, Gong X, Li A, Liu Y, Li X, Zhou D, Hong Z. Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature. Front Immunol. 2023;14:1146536.","journal-title":"Front Immunol"},{"issue":"43","key":"4615_CR34","doi-asserted-by":"publisher","first-page":"e31063","DOI":"10.1097\/MD.0000000000031063","volume":"101","author":"T Huo","year":"2022","unstructured":"Huo T, Luo X, Zhao J, Wang T, Chen J. A Chinese female patient with LGI1 and mGluR5 antibodies: A case report. Med (Baltim). 2022;101(43):e31063.","journal-title":"Med (Baltim)"},{"issue":"33","key":"4615_CR35","doi-asserted-by":"publisher","first-page":"e39146","DOI":"10.1097\/MD.0000000000039146","volume":"103","author":"J He","year":"2024","unstructured":"He J, Niu X, Chen X, Ma B, Ren Y, Qi W, Zhan X, Meng Y, Li J, Li H. Overlapping syndrome of anti-MOG antibody-associated disease and anti-mGluR5 encephalitis manifested as optic neuritis: A case report. Med (Baltim). 2024;103(33):e39146.","journal-title":"Med (Baltim)"},{"issue":"22","key":"4615_CR36","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planagum\u00e0 J, Mart\u00ednez-Hernandez E, Armangu\u00e9 T, Pr\u00fcss H, Iizuka T, Capar\u00f3 Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J. Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology. 2018;90(22):e1964\u201372.","journal-title":"Neurology"},{"key":"4615_CR37","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3389\/fimmu.2018.02568","volume":"9","author":"C Guevara","year":"2018","unstructured":"Guevara C, Farias G, Silva-Rosas C, Alarcon P, Abudinen G, Espinoza J, Caro A, Angus-Leppan H, de Grazia J. Encephalitis associated to metabotropic glutamate receptor 5 (mGluR5) antibodies in cerebrospinal fluid. Front Immunol. 2018;9:2568.","journal-title":"Front Immunol"},{"key":"4615_CR38","doi-asserted-by":"publisher","first-page":"808131","DOI":"10.3389\/fimmu.2022.808131","volume":"13","author":"W Yan","year":"2022","unstructured":"Yan W, Zhao C, Zhang H, Hu Z, Wang C. Case report: Guillain-Barr\u00e9 syndrome characterized by severe headache associated with metabotropic glutamate receptor 5 antibody. Front Immunol. 2022;13:808131.","journal-title":"Front Immunol"},{"issue":"4","key":"4615_CR39","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/NXI.0000000000001171","volume":"9","author":"AM Vinke","year":"2022","unstructured":"Vinke AM, Zong S, Janssen JH, et al. Autoimmune encephalitis with mGluR1 antibodies presenting with epilepsy, but without cerebellar signs: a case report. Neurol Neuroimmunol Neuroinflamm. 2022;9(4):e1171 (Published 2022 Apr 21).","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"4615_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","volume":"326","author":"F Ferraguti","year":"2006","unstructured":"Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res. 2006;326(2):483\u2013504.","journal-title":"Cell Tissue Res"},{"issue":"8276","key":"4615_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","volume":"1","author":"I Carr","year":"1982","unstructured":"Carr I. The ophelia syndrome: memory loss in Hodgkin\u2019s disease. Lancet. 1982;1(8276):844\u20135.","journal-title":"Lancet"},{"issue":"21","key":"4615_CR42","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1158\/1078-0432.CCR-12-1308","volume":"18","author":"S Koochekpour","year":"2012","unstructured":"Koochekpour S, Majumdar S, Azabdaftari G, et al. Serum glutamate levels correlate with Gleason score and glutamate Blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res. 2012;18(21):5888\u2013901.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4615_CR43","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/sj.bjp.0706746","volume":"148","author":"A Chiocchetti","year":"2006","unstructured":"Chiocchetti A, Miglio G, Mesturini R, et al. Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol. 2006;148(6):760\u20138.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04615-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:03:56Z","timestamp":1772629436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04615-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4615"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04615-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This subject have been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided consent for the publication of this case report and consent for publication of clinical details and clinical images. All informed consent was informed written. Regarding minors under the age of 18, consent for the publication of clinical details and images was provided by their parents or guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}